Jamal Mahajna is an Associate Professor at the Cancer Drug Discovery Program, Migal, Galilee Research Institute Department of Nutritional Sciences, Tel Hai College, Israel. He completed his Ph.D. studies at the Hebrew University in Jerusalem and has been awarded several awards and honors. His interests include cancer drug resistance.
Research Keywords & Expertise
Cancer
CML
Ovarian Cancer
natural product
chemo-resistant
kinase inhibitor
Fingerprints
64%
Cancer
16%
chemo-resistant
15%
CML
15%
kinase inhibitor
12%
Ovarian Cancer
12%
natural product
Short Biography
Jamal Mahajna is an Associate Professor at the Cancer Drug Discovery Program, Migal, Galilee Research Institute Department of Nutritional Sciences, Tel Hai College, Israel. He completed his Ph.D. studies at the Hebrew University in Jerusalem and has been awarded several awards and honors. His interests include cancer drug resistance.